Ask AI

Tuning in to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs

For advanced practice providers, gain in-depth knowledge on the role TYK2 plays in the pathophysiology of psoriasis and strategies for integrating TYK2-targeted, oral therapy in personalized treatment plans for patients with moderate to severe disease, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

TYK2 inhibition in psoriasis
The Evolving Psoriasis Treatment Landscape—From Injectable Biologics to Novel, Oral Small Molecules Targeting TYK2
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2025

Expires: October 22, 2026

Activities

Oral TYK2 psoriasis treatment
Tuning In to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 16, 2025

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (Partners)

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb